Entegris Inc
NASDAQ:ENTG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Entegris Inc
NASDAQ:ENTG
|
US |
|
Asahi Kasei Corp
TSE:3407
|
JP |
|
Capitol Health Ltd
ASX:CAJ
|
AU |
|
Bakrie & Brothers Tbk PT
IDX:BNBR
|
ID |
|
Runben Biotechnology Co Ltd
SSE:603193
|
CN |
|
Timah Tbk PT
IDX:TINS
|
ID |
|
Navigator Global Investments Ltd
ASX:NGI
|
AU |
Wall St Price Targets
ENTG Price Targets Summary
Entegris Inc
According to Wall Street analysts, the average 1-year price target for ENTG is 163.14 USD with a low forecast of 116.15 USD and a high forecast of 215.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ENTG's stock price target?
Price Target
163.14
USD
According to Wall Street analysts, the average 1-year price target for ENTG is 163.14 USD with a low forecast of 116.15 USD and a high forecast of 215.25 USD.
What is the Revenue forecast for Entegris Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Entegris Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 5 years is 20%.
What is the Net Income forecast for Entegris Inc?
Projected CAGR
25%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 25%.
